相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Dilja D. Krueger et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Reduced Interhemispheric Resting State Functional Connectivity in Cocaine Addiction
Clare Kelly et al.
BIOLOGICAL PSYCHIATRY (2011)
Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting
Catalina Betancur
BRAIN RESEARCH (2011)
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
L. M. DeVito et al.
GENES BRAIN AND BEHAVIOR (2011)
Autism spectrum disorders-A genetics review
Judith H. Miles
GENETICS IN MEDICINE (2011)
Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: A phantom study at 4 Tesla
Michael E. Henry et al.
JOURNAL OF MAGNETIC RESONANCE (2011)
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
Matthew S. Kayser et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Murine diffusion imaging using snapshot interleaved EPI acquisition at 7T
David N. Guilfoyle et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Diffusion based abnormality markers of pathology: Toward learned diagnostic prediction of ASD
Madhura Ingalhalikar et al.
NEUROIMAGE (2011)
Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness
Karyn M. Myers et al.
NEUROPSYCHOPHARMACOLOGY (2011)
A Randomized Experimental Investigation of Reasoning Training for People With Delusions
Kerry Ross et al.
SCHIZOPHRENIA BULLETIN (2011)
Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
Sebastien Jacquemont et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Candidate Electrophysiological Endophenotypes of Hyper-Reactivity to Change in Autism
Marie Gomot et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Validating γ Oscillations and Delayed Auditory Responses as Translational Biomarkers of Autism
Michael J. Gandal et al.
BIOLOGICAL PSYCHIATRY (2010)
Ceftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking
Lori A. Knackstedt et al.
BIOLOGICAL PSYCHIATRY (2010)
Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly
Yvette I. Sheline et al.
BIOLOGICAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Sensitization of rat facial cutaneous mechanoreceptors by activation of peripheral N-methyl-D-aspartate receptors
Parisa Gazerani et al.
BRAIN RESEARCH (2010)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
V. Labrie et al.
GENES BRAIN AND BEHAVIOR (2010)
Functional Connectivity in Blood Oxygenation Level-Dependent and Cerebral Blood Volume-Weighted Resting State Functional Magnetic Resonance Imaging in the Rat Brain
Matthew Magnuson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Drug-Induced Plasticity Contributing to Heightened Relapse Susceptibility: Neurochemical Changes and Augmented Reinstatement in High-Intake Rats
Aric Madayag et al.
JOURNAL OF NEUROSCIENCE (2010)
1H-MRS at 4 Tesla in minimally treated early schizophrenia
J. R. Bustillo et al.
MOLECULAR PSYCHIATRY (2010)
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
L. Verrall et al.
MOLECULAR PSYCHIATRY (2010)
Brain Serotonin Transporter Occupancy by Oral Sibutramine Dosed to Steady State: A PET Study Using 11C-DASB in Healthy Humans
Peter S. Talbot et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine
Giacomo Salvadore et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Fragile X: Leading the Way for Targeted Treatments in Autism
Lulu W. Wang et al.
NEUROTHERAPEUTICS (2010)
Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5
Cyrill Burger et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Functional connectivity density mapping
Dardo Tomasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Resting Brain Connectivity: Changes during the Progress of Alzheimer Disease
Hong-Ying Zhang et al.
RADIOLOGY (2010)
Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA BULLETIN (2010)
Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI study
Matthew J. Hoptman et al.
SCHIZOPHRENIA RESEARCH (2010)
Transition to Addiction Is Associated with a Persistent Impairment in Synaptic Plasticity
Fernando Kasanetz et al.
SCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Identification and Evaluation of [11C]GSK931145 as a Novel Ligand for Imaging the Type 1 Glycine Transporter With Positron Emission Tomography
J. Passchier et al.
SYNAPSE (2010)
Brief Report: Acamprosate in Fragile X Syndrome
Craig A. Erickson et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2010)
White Matter Integrity and Prediction of Social and Role Functioning in Subjects at Ultra-High Risk for Psychosis
Katherine H. Karlsgodt et al.
BIOLOGICAL PSYCHIATRY (2009)
The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans
Lori A. Knackstedt et al.
BIOLOGICAL PSYCHIATRY (2009)
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2009)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist
Laura E. Phelps et al.
BIOLOGICAL PSYCHIATRY (2009)
Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine
Giacomo Salvadore et al.
BIOLOGICAL PSYCHIATRY (2009)
Redox dysregulation, neurodevelopment, and schizophrenia
Kim Q. Do et al.
CURRENT OPINION IN NEUROBIOLOGY (2009)
Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Rodrigo Machado-Vieira et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
James M. Stone
CURRENT PHARMACEUTICAL DESIGN (2009)
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Viviane Labrie et al.
HUMAN MOLECULAR GENETICS (2009)
Upregulation of Glt1 Attenuates Cue-Induced Reinstatement of Cocaine-Seeking Behavior in Rats
Youssef Sari et al.
JOURNAL OF NEUROSCIENCE (2009)
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
A. C. Basu et al.
MOLECULAR PSYCHIATRY (2009)
N-Acetylcysteine reverses cocaine-induced metaplasticity
Khaled Moussawi et al.
NATURE NEUROSCIENCE (2009)
The glutamate homeostasis hypothesis of addiction
Peter W. Kalivas
NATURE REVIEWS NEUROSCIENCE (2009)
Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia
Robert A. Sweet et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Molecular Genetics of Addiction and Related Heritable Phenotypes Genome-Wide Association Approaches Identify Connectivity Constellation and Drug Target Genes with Pleiotropic Effects
George R. s Uhl et al.
ADDICTION REVIEWS 2008 (2008)
N-acetylcysteine reduces extinction responding and induces enduring reductions in cue-and heroin-induced drug-seeking
Wenhua Zhou et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats
Dmitry Tikhonravov et al.
BRAIN RESEARCH (2008)
The Autistic Neuron: Troubled Translation?
Raymond J. Kelleher et al.
CELL (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice
Richard S. Ehrlichman et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2008)
Schizophrenia: Moving beyond monoamine antagonists
P. Jeffrey Conn et al.
MOLECULAR INTERVENTIONS (2008)
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
Nicole C. Allen et al.
NATURE GENETICS (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
Karsten Heekeren et al.
PSYCHOPHARMACOLOGY (2008)
GABA neurons and the mechanisms of network oscillations: Implications for understanding cortical dysfunction in schizophrenia
Guillermo Gonzalez-Burgos et al.
SCHIZOPHRENIA BULLETIN (2008)
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Caroline Madeira et al.
SCHIZOPHRENIA RESEARCH (2008)
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia
Tom Walsh et al.
SCIENCE (2008)
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
Eduardo Dunayevich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Mismatch negativity in children with autism and typical development
Michelle A. Dunn et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2008)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Children and adolescents with autism exhibit reduced MEG steady-state gamma responses
Tony W. Wilson et al.
BIOLOGICAL PSYCHIATRY (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
NMDA receptors and schizophrenia
Lars V. Kristiansen et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
5-Hydroxytryptamine2A(5-HT2A) receptor regulation in rat prefrontal cortex:: Interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740
Gerard J. Marek et al.
NEUROSCIENCE LETTERS (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens
Miquel Martin et al.
NATURE NEUROSCIENCE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Ketamine produces lasting disruptions in encoding of sensory stimuli
CR Maxwell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
PET and SPET molecular imaging: Focus on serotonin system
Rosa Maria Moresco et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
The neural basis of addiction: A pathology of motivation and choice
PW Kalivas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Mismatch negativity in schizophrenia: a meta-analysis
D Umbricht et al.
SCHIZOPHRENIA RESEARCH (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice
AM Linden et al.
PSYCHOPHARMACOLOGY (2005)
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
JH Krystal et al.
PSYCHOPHARMACOLOGY (2005)
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)
MP Johnson et al.
PSYCHOPHARMACOLOGY (2005)
Deviance-related electrophysiological activity in mice: is there mismatch negativity in mice?
D Umbricht et al.
CLINICAL NEUROPHYSIOLOGY (2005)
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
CJ Swanson et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Mismatch negativity deficits are associated with poor functioning in schizophrenia patients
GA Light et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
Kenji Hashimoto et al.
BMC PSYCHIATRY (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Midlatency auditory event-related potentials in mice: Comparison to midlatency auditory ERPs in humans
D Umbricht et al.
BRAIN RESEARCH (2004)
Drug seeking becomes compulsive after prolonged cocaine self-administration
LJMJ Vanderschuren et al.
SCIENCE (2004)
Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats
CM Padovan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Auditory event-related potential abnormalities in bipolar disorder and schizophrenia
BF O'Donnell et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2004)
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
MOLECULAR PSYCHIATRY (2004)
LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress
DD Schoepp et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2003)
How specific are deficits in mismatch negativity generation to schizophrenia?
D Umbricht et al.
BIOLOGICAL PSYCHIATRY (2003)
Neuropsychiatric applications of DTI - a review
KO Lim et al.
NMR IN BIOMEDICINE (2002)
Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex
RZ Goldstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Preclinical Pharmacology of mGlu2/3 Receptor Agonists: Novel Agents for Schizophrenia?
Darryle D. Schoepp et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Effect of ketamine on the neuromagnetic mismatch field in healthy humans
I Kreitschmann-Andermahr et al.
COGNITIVE BRAIN RESEARCH (2001)
Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum
J Cartmell et al.
BRAIN RESEARCH (2000)
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers -: Implications for models of cognitive deficits in schizophrenia
D Umbricht et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Deficits in auditory and visual context-dependent processing in schizophrenia -: Defining the pattern
DC Javitt et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Regulation of neurotransmitter release by metabotropic glutamate receptors
J Cartmell et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Mismatch negativity in aging and in Alzheimer's and Parkinson's diseases
E Pekkonen
AUDIOLOGY AND NEURO-OTOLOGY (2000)
Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia
DC Javitt
AUDIOLOGY AND NEURO-OTOLOGY (2000)
Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP)
DC Javitt et al.
CLINICAL NEUROPHYSIOLOGY (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
The effects of a sub-anaesthetic dose of ketamine on human selective attention
B Oranje et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
